Work

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Year: 2015

Type: erratum

Abstract: During the editorial process preceding the publication of this article an error was introduced in the heading of "Table 1 Univariate and multivariate analysis of elafinpositive cells in breast cancer patients."This error was only noticed after publication of the final version.Specifically, both data-containing columns are labeled "Elafin Negative."The data-containing column on the right should in fact be labeled "Elafin Positive (n = 482)."The corrected version can be found here (Table 1).Table 1 has also been updated in the original article to reflect the correct labeling of the columns.

Source: Breast Cancer Research

DOI: 10.1186/s13058-015-0572-5

Authors: Joseph A Caruso, Cansu Karakas, Jing Zhang, Min Yi, Constance Albarracin, Aysegul Sahin, Melissa Bondy, Jinsong Liu, Kelly K. Hunt, Khandan Keyomarsi

Institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,190

OpenAlex ID: W2588716626

Cites: 1

Cited by: 1

Related to: 10